Leonardo Fleury Orlandini
Identification of a Subtype of Poorly Differentiated Invasive Ductal Carcinoma of the Breast Based on Vimentin and E-cadherin Expression
Orlandini, Leonardo Fleury; Reis, Francisco José Cândido dos; da Silveira, Willian Abraham; Tiezzi, Marcelo Guimarães; de Andrade, Jurandyr Moreira; Ribeiro-Silva, Alfredo; Deaton, Ryan; Bosland, Maarten; Tiezzi, Daniel Guimarães
Authors
Francisco José Cândido dos Reis
Dr Willian Da Silveira W.A.DaSilveira@salford.ac.uk
Lecturer
Marcelo Guimarães Tiezzi
Jurandyr Moreira de Andrade
Alfredo Ribeiro-Silva
Ryan Deaton
Maarten Bosland
Daniel Guimarães Tiezzi
Abstract
Objective: The use of molecular markers can identify a subgroup of tumors with distinct recurrence patterns. The present study aimed to characterize the immunohistochemical expression of vimentin (VIM), of E-cadherin (CDH1), and of cytokeratin 5 (CK5) in patients with invasive ductal carcinomas (IDCs).
Methods: We have constructed a tissue microarray (TMA) from 87 patients with IDC of the breast. Immunohistochemistry (IHC) was performed to study the expression of estrogen and progesterone receptors (ER and PgR), human epidermal growth factor receptor 2 (HER2), VIM, CDH1, CK5, and Ki67. The tumors were classified as luminal A and B (n = 39), HER2 enriched (n = 25), and triple-negative (TNBC) (n = 23), based on the IHC expression.
Results: We have observed that luminal A and B tumors lack the VIM+/CDH1-/low phenotype. This phenotype was observed in 16.5% of the HER2+ tumors and in 60% of the TNBC tumors (p = 0.0001). Out of a total of 20 TNBC tumors, the CK5 (basal-like marker) was positive in 11 of them. The VIM+/CDH1-/low phenotype was observed in 5 CK5+ TNBC tumors (45%) and in 7 out of 9 CK5- TNBC tumors (78%) (p = 0.02). The median Ki67 index in the VIM+/CDH1-/low tumors was 13.6 (range: 17.8-45.4) compared with 9.8 (range: 4.1-38.1) in other tumors (p = 0.0007). The presence of lymph node metastasis was less frequent in patients with VIM+/CDH1-/low tumors (23% versus 61%; X2 test; p = 0.01).
Conclusion: Our findings suggest that the expression of VIM and CDH1 can identify a subset of IDCs of the breast with a mesenchymal phenotype associated with poor prognosis, high-grade lesion, and high mitotic index.
Citation
Orlandini, L. F., Reis, F. J. C. D., da Silveira, W. A., Tiezzi, M. G., de Andrade, J. M., Ribeiro-Silva, A., …Tiezzi, D. G. (2018). Identification of a Subtype of Poorly Differentiated Invasive Ductal Carcinoma of the Breast Based on Vimentin and E-cadherin Expression. Revista Brasileira de Ginecologia e Obstetrícia, 40(12), 779-786. https://doi.org/10.1055/s-0038-1673700
Journal Article Type | Article |
---|---|
Online Publication Date | Oct 25, 2018 |
Publication Date | 2018-12 |
Deposit Date | Oct 25, 2024 |
Publicly Available Date | Oct 25, 2024 |
Journal | Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics |
Print ISSN | 0100-7203 |
Electronic ISSN | 1806-9339 |
Publisher | Thieme Gruppe |
Peer Reviewed | Peer Reviewed |
Volume | 40 |
Issue | 12 |
Pages | 779-786 |
DOI | https://doi.org/10.1055/s-0038-1673700 |
Files
Published Version
(421 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
You might also like
Downloadable Citations
About USIR
Administrator e-mail: library-research@salford.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search